The VELscope Vx helps us identify oral disease early, while it’s still easy to treat. One of the VELscope’s most important tasks is to help locate areas that might, if not treated, progress to oral cancer.
- Found early, oral cancer’s 5-year survival rate is good: approx. 83%.
- Found late, oral cancer’s 5-year survival rate is poor: approx. 32%.
- Clearly, finding oral cancer in its early stages is key to survival.
The VELscope Vx offers hope for the early discovery of oral disease, including precancer and cancer.